Epredia’s Journey, Upcoming Webinar Hosted by Xtalks


MedTech companies need to focus on connecting quality and regulatory to harmonize the product lifecycle.

With the rapid changes in MedTech, the regulations and quality requirements also need to keep pace and address specific needs across different geographies. To do this, MedTech companies need to focus on connecting quality and regulatory to harmonize the product lifecycle.

Epredia, a global precision cancer diagnostics company, is doing just that. Epredia has consolidated four siloed systems into a single quality platform with a clear path to unify regulatory affairs and quality assurance. This harmonization helps eliminate manual efforts, reduce compliance risk and speed the total product lifecycle.

Join Mark Ramser, Senior Director – Global Quality, Epredia and Brian Scogland, Director Regulatory Strategy, Veeva MedTech in a live webinar on Thursday, April 15, 2021 at 1pm EDT to hear about best practices and lessons learned in their journey to modernize their quality and regulatory systems, including connecting quality documentation, training, a new RIM solution, future connections to CAPA, complaints and change control.

For more information, or to register for this event, visit Harmonizing QA & RA in MedTech: Epredia’s Journey.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Leave a Reply